EU launch of ECOVAXXIN® MS

Eco Animal Health Group PLC

02 July 2026

 

2 July 2026

ECO Animal Health Group plc

("ECO" or the "Company")

EU launch of ECOVAXXIN® MS

ECO Animal Health Group plc (AIM: EAH), a leading global animal health company marketing and developing branded veterinary products to improve livestock productivity and welfare, announces the commercial launch of ECOVAXXIN® MS, its poultry vaccine against Mycoplasma synoviae (M. synoviae), across the European Union (EU) with its official launch event in Madrid, Spain.  

ECOVAXXIN® MS represents the first product from ECO's proprietary R&D pipeline to reach commercial market entry. The vaccine provides active immunisation of future layer and breeder chickens from four weeks of age, to reduce air-sac and foot-pad lesions and egg production losses caused by M. synoviae infections. The infection causes significant economic loss, particularly in laying hens, where egg production in affected layers can be reduced by 5-10%.

Andrew Buglass, Chief Commercial Officer of ECO Animal Health, commented: "ECOVAXXIN® MS is a best-in-class vaccine backed by an established EU commercial infrastructure and a network of committed distribution partners ready to reach producers at scale. We believe this will deliver meaningful clinical benefit for layer and breeder flocks across Europe and look forward to building on this commercial momentum across our launch markets."

ECO is leveraging its established commercial network, built for Aivlosin®, to deliver comprehensive market coverage with strategic distribution agreements in place across the major poultry markets in the EU, providing access to markets representing over 220 million layer-birds annually.

The Company is also progressing registration in USA, Latin American and Asian markets.  

-Ends-

Contacts

ECO Animal Health Group plc David Hallas (Chief Executive Officer) Christopher Wilks (Chief Financial Officer)	020 8447 8899
ICR Healthcare (Financial PR) Mary-Jane Elliott Jessica Hodgson	020 3709 5700
Singer Capital Markets (Nominated Adviser & Joint Broker) Jen Boorer Jalini Kalaravy Samed Ethemi	020 7496 3000
Panmure Liberum (Joint Broker) Emma Earl Will Goode Mark Rogers Rupert Dearden	020 3100 2000
Equity Development Hannah Crowe Matt Evans	020 7065 2692

About ECO Animal Health

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.

Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.

Our lead product, Aivlosin^® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.

Click here for more information: https://ecoanimalhealth.com

 

END